Listed

Denali Therapeutics Inc.

DNLINasdaqCIK 1714899HealthcareFiscal year ends Dec 31

Reports and events: 152 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Denali Therapeutics Inc., Reports and events
FiledFormWhat it isAccession number
2024-01-0808:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001714899-24-000031
2023-11-0716:05 ET10-QQuarterly reportPeriod 2023-09-300001714899-23-000146
2023-11-0716:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001714899-23-000145
2023-08-2116:06 ET8-K1.01 Entry into a material agreement0001714899-23-000131
2023-08-0816:05 ET10-QQuarterly reportPeriod 2023-06-300001714899-23-000120
2023-08-0816:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001714899-23-000119
2023-06-2007:03 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001714899-23-000103
2023-06-0508:12 ET8-K8.01 Other events0001193125-23-160341
2023-06-0216:05 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001714899-23-000079
2023-05-0816:06 ET10-QQuarterly reportPeriod 2023-03-310001714899-23-000075
2023-05-0816:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001714899-23-000074
2023-04-1816:02 ETDEF 14AProxy statement0001714899-23-000062
2023-02-2716:06 ET10-KAnnual reportPeriod 2022-12-310001714899-23-000049
2023-02-2716:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001714899-23-000048
2023-01-0908:08 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001714899-23-000008
2022-11-0316:07 ET10-QQuarterly reportPeriod 2022-09-300001714899-22-000144
2022-11-0316:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001714899-22-000143
2022-10-2016:58 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001628280-22-026765
2022-10-1817:09 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001628280-22-026572
2022-08-0816:06 ET10-QQuarterly reportPeriod 2022-06-300001714899-22-000123
2022-08-0816:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001714899-22-000122
2022-07-0508:01 ET8-K7.01 Regulation FD disclosure0001714899-22-000105
2022-06-0316:01 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001714899-22-000082
2022-05-0516:05 ET10-QQuarterly reportPeriod 2022-03-310001714899-22-000078
2022-05-0516:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001714899-22-000077
2022-04-1916:02 ETDEF 14AProxy statementPeriod 2022-06-020001714899-22-000068
2022-03-1616:20 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-22-077264
2022-02-2817:27 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001628280-22-004300
2022-02-2816:19 ET10-KAnnual reportPeriod 2021-12-310001714899-22-000058
2022-02-2816:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001714899-22-000056
2022-02-1406:29 ET8-K7.01 Regulation FD disclosure0001193125-22-039150
2022-02-1009:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001714899-22-000028
2022-02-0716:03 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001714899-22-000021
2022-01-1009:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001714899-22-000014
2021-11-1709:03 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001714899-21-000113
2021-11-0416:07 ET10-QQuarterly reportPeriod 2021-09-300001714899-21-000106
2021-11-0416:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001714899-21-000105
2021-08-0416:07 ET10-QQuarterly reportPeriod 2021-06-300001714899-21-000078
2021-08-0416:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001714899-21-000077
2021-07-2608:29 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001714899-21-000066
2021-06-0416:04 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001714899-21-000058
2021-05-0508:31 ET10-QQuarterly reportPeriod 2021-03-310001714899-21-000054
2021-05-0308:34 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001714899-21-000050
2021-04-2208:46 ETDEF 14AProxy statementPeriod 2021-06-020001714899-21-000042
2021-02-2608:35 ET10-KAnnual reportPeriod 2020-12-310001714899-21-000033
2021-02-2516:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001714899-21-000022
2021-02-1207:48 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001714899-21-000018
2021-02-1015:57 ET8-K/A5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001714899-21-000010
2021-02-0516:43 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-030764
2021-01-1108:46 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001714899-21-000007

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 3, 2026, 19:01 ET. Listed shows no prices and gives no investment advice.